
Progyny, Inc.
PGNYNASDAQHealthcare● Active
$25.92
+$0.06(+0.23%)
Market Cap$2.0B
P/E Ratio—
52W High$28.75
52W Low$16.1
Progyny, Inc.(PGNY)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · PGNY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.29B | $1.17B | $1.09B | $0.79B | $0.50B |
| Cost of Revenue | $0.98B | $0.91B | $0.85B | $0.62B | $0.39B |
| Gross Profit | $0.30B | $0.25B | $0.24B | $0.17B | $0.11B |
| Gross Margin %(computed) | 23.63% | 21.71% | 21.94% | 21.26% | 22.40% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.15B | $0.12B | $0.12B | $0.10B | $0.06B |
| Total Operating Expenses | $0.22B | $0.19B | $0.18B | $0.14B | $0.08B |
| Operating Income | $0.09B | $0.07B | $0.06B | $0.02B | $0.03B |
| Operating Margin %(computed) | 6.62% | 5.78% | 5.71% | 2.97% | 6.46% |
| Interest Income | $0.00B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.10B | $0.08B | $0.07B | $0.02B | $0.03B |
| Income Tax Expense | $0.04B | $0.03B | $0.01B | ($0.01B) | ($0.03B) |
| Net Income | $0.06B | $0.05B | $0.06B | $0.03B | $0.07B |
| Net Margin %(computed) | 4.54% | 4.66% | 5.70% | 3.86% | 13.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.68 | $0.59 | $0.65 | $0.33 | $0.74 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.10B | 0.09B | 0.09B |
| EBITDA | $0.10B | $0.07B | $0.06B | $0.02B | $0.03B |
| EBITDA Margin %(computed) | 7.79% | 6.05% | 5.92% | 3.17% | 6.72% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Progyny, Inc.
关于Progyny, Inc.(PGNY)损益表
Progyny, Inc.(PGNY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PGNY实现营收$1.29B,毛利润$0.30B(毛利率23.63%),净利润$0.06B(净利率4.54%)。
常见问题
PGNY · 4 问Progyny, Inc.(PGNY)2025财年营收为$1.29B,同比up10.4%。
PGNY revenuePGNY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08